Insider Selling on a Hot Day
On May 18, 2026, DUCHENE TODD M sold a total of 10,000 shares of Core Scientific Inc. through a Rule 10b‑5‑1 trading plan. The shares were liquidated at an average price of $23.12, barely a 0.01 % decline from the closing price of $22.92 that day. The transaction coincided with a sharp uptick in social‑media buzz—over 40 % higher than normal—yet the sentiment remained strongly positive (+39). For most investors, the price impact of this sale is modest, but the timing raises questions about the broader context of insider activity.
A Pattern of Gradual Unloading
Looking back through the past three months, DUCHENE has sold more than 200,000 shares, trimming his stake from 2.15 M to 1.96 M shares. His sales have spanned a wide price range—from $15.25 in early April to $23.39 in mid‑May—suggesting a systematic, plan‑based approach rather than panic selling. The cumulative average sale price of $22.12 is roughly 4 % below the company’s 52‑week high ($25.17), implying a valuation view that is slightly bearish but still within a profitable band for a long‑term holder.
What Does This Mean for Investors?
Core Scientific’s fundamentals remain solid: a market cap of $7.7 B, a strong AI‑and‑mining pivot, and an “Outperform” rating from Bernstein. The insider sales could be interpreted in two ways:
- Portfolio Rebalancing – The structured plan and wide price spread suggest a deliberate reallocation of assets, not a signal of imminent trouble.
- Signal of Confidence Shift – The consistent downsizing of his position, coupled with the timing of the sale on a high‑buzz day, may indicate that the insider believes the current price overstates future growth, particularly if the AI build‑out stalls.
For cautious investors, the sale may be a cue to re‑evaluate exposure, especially given the sector‑wide regulatory and grid‑capacity headwinds highlighted by analysts. For those bullish on Core Scientific’s AI trajectory, the insider’s disciplined approach could be a green light to maintain or incrementally increase positions.
Profile: DUCHENE TODD M
DUCHENE is a long‑standing insider whose trading history shows a preference for rule‑based selling. He has never disclosed a direct role in company management, yet his consistent, sizable sales across multiple months reflect deep familiarity with Core Scientific’s financial cycles. Over the last 12 months, his net sales have totaled roughly 400,000 shares, with a net proceeds value exceeding $9 million. The absence of large, opportunistic purchases suggests that his primary motive is portfolio balance rather than speculation.
Bottom Line
While the May 18 sale is statistically insignificant in market terms, its placement within a broader, systematic unloading pattern offers a nuanced perspective for investors. Core Scientific remains a compelling play on AI and mining, but insiders appear to be gradually scaling back, perhaps signaling a more conservative outlook. Investors should weigh the company’s growth narrative against the insider’s measured divestiture when deciding how to position themselves.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-05-18 | DUCHENE TODD M (See remarks) | Sell | 9,600.00 | 23.12 | Common Stock |
| 2026-05-18 | DUCHENE TODD M (See remarks) | Sell | 400.00 | 23.76 | Common Stock |




